Document:

Form of Resale Restriction Agreement

 EXHIBIT 10.1 
  
 BIOLASE TECHNOLOGY, INC. 
  
 RESALE RESTRICTION AGREEMENT 
  
 This RESALE RESTRICTION AGREEMENT (the “Agreement”) with respect to certain stock option award agreements (the “Option
Agreements”) issued under the BIOLASE Technology, Inc. 2002 Stock Incentive Plan (the “Plan”) is made by and between BIOLASE Technology, Inc., a Delaware corporation (the “Company”), and
[                                    ] (the
“Holder”). 
  
 WHEREAS, the Holder has been
granted one or more options (the “Options”) to acquire shares of common stock of the Company (the “Shares”) in such quantities and at the exercise prices set forth in Exhibit A hereto pursuant to the Option
Agreements; 
  
 WHEREAS, subject to the Holder agreeing to the
terms of this Agreement, the Options are fully vested and exercisable by reason of an action of the Compensation Committee of the Company’s Board of Directors effective December 16, 2005; and 
  
 WHEREAS, the Company and the Holder wish to impose certain resale
restrictions on the Shares subject to the Options, as provided herein on the terms and conditions contained herein. 
  
 NOW, THEREFORE, it is agreed as follows: 
  
 1. The Holder acknowledges that he or she has reviewed this Agreement in full. The Holder further acknowledges that the Holder has consented to the
acceleration of vesting of the Options, notwithstanding any effect that the acceleration of vesting may have on the status of the Options as incentive stock options under the Internal Revenue Code (if applicable). 
  
 2. The Holder agrees not to sell, contract to sell, grant any option to
purchase, transfer the economic risk of ownership in, make any short sale of, pledge or otherwise transfer or dispose of any Shares (or any interest in any Shares) until the Shares have been released from the foregoing resale restrictions
(hereinafter referred to as the “Resale Restrictions”), except as may be necessary to satisfy withholding taxes related to the exercise of the Option. 
  
 3. The Holder agrees that all of the Shares subject to Options set forth in Exhibit A shall be subject to the Resale
Restrictions. 
  
 4. The Resale Restrictions shall lapse in
accordance with the original vesting schedule with respect to each grant referenced in Exhibit A. 
  
 5. The Holder acknowledges and agrees that in the event the Holder’s employment or service with the Company is terminated for any reason, the Shares
subject to the Option shall not become free from the Resale Restrictions, and such Resale Restrictions shall continue to lapse based upon the schedule set forth in Exhibit A. 

 6. The Holder acknowledges and agrees that the stock certificate issued as a result of the exercise of
any of the Options set forth in Exhibit A shall bear the following restrictive legend which restricts the transferability of the Shares: 
  
 THE SALE, PLEDGE, HYPOTHECATION, ASSIGNMENT OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE IS SUBJECT TO THE TERMS AND CONDITIONS OF A
RESALE RESTRICTION AGREEMENT BY AND BETWEEN THE STOCKHOLDER AND THE CORPORATION. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION. 
  
 7. This Agreement shall be effective as of December 16, 2005. 
  
 8. The Holder represents and warrants that he or she has full power to enter
into this Agreement. 
  
 9. This Agreement, the Option Agreement
and the Plan constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior understandings and agreements of the Company and the Holder with respect to the subject matter hereof,
and may not be modified except by means of a writing signed by the Company and the Holder. This Agreement is to be construed in accordance with and governed by the internal laws of the State of California without giving effect to any choice of law
rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties. Nothing in this Agreement (except as expressly provided herein) is intended to
confer any rights or remedies on any persons other than the parties. Should any provision of this Agreement be determined to be illegal or unenforceable, such provision shall be enforced to the fullest extent allowed by law and the other provisions
shall nevertheless remain effective and shall remain enforceable. 
  
 10. This Agreement shall be binding upon the Company and the Holder as well as the successors and assigns (if any) of the Company and the Holder. 
  
 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed and delivered on the date set forth beside such party’s signature.

  

			
	 BIOLASE TECHNOLOGY, INC.

		
	By:	 	 

			
	 Print Name:
	 	 

			
	 Title:
	 	 

  

			
	 HOLDER

	
	 

			
	 Print Name:
	 	 

 SCHEDULE TO 
 BIOLASE TECHNOLOGY, INC. 
 RESALE RESTRICTION AGREEMENT 
  
 The foregoing form of BIOLASE Technology, Inc. (“BIOLASE”) Resale
Restriction Agreement was entered into between BIOLASE and the following executive officers, effective December 16, 2005, with respect to the acceleration of vesting for the following unvested stock option shares: 
  

					
	 Name

	  	 Title

	  	Unvested Shares

	Robert E. Grant	  	President and Chief Executive Officer	  	289,178
			
	Richard L. Harrison	  	Executive Vice President, Chief Financial Officer and Secretary	  	250,000
			
	James M. Haefner	  	Executive Vice President Sales	  	120,000
			
	Keith G. Bateman	  	Executive Vice President Marketing	  	25,000Summary of the Registrant's Non-employee Director Compensation

 EXHIBIT 10.1 
  
 Non-Employee Director Compensation 
  
 Cash Compensation 
  

			
	Board Annual Retainer	  	$30,000
	 Scheduled Board Meeting Fees
 (for 100% attendance
at four quarterly,
 regularly scheduled Board meetings)
	  	$10,000
	Special Board Meeting Fee	  	$1,000/special meeting
	Per Diem Fee	  	$1,250/day for special projects and director
training as authorized by the Company
		
	Committee Member Annual Retainers:	  	 
	Audit Committee	  	Chairman = $10,000/Members =$5,000
	Compensation Committee	  	Chairman = $10,000/Members =$5,000
	Nominating and Governance Committee	  	Chairman = $5,000/Members =$2,500
	
	Equity Compensation
	Board Annual Equity Award	  	$80,000 in restricted stock
		
	Committee Member Annual Equity Awards:	  	 
	Audit Committee	  	Chairman $10,000 in restricted
stock/Members $5,000 in restricted stock
	Compensation Committee	  	Chairman $10,000 in restricted
stock/Members $5,000 in restricted stock
	Nominating and Governance Committee	  	N/A

  
 Annual cash retainers will be paid in
four quarterly installments. Equity awards will be granted annually on the last day of each Board year (with the first grant date to be the date of the Company’s 2006 annual shareholders’ meeting), provided that an individual remains a
Board/Committee member on such date. The shares of restricted stock granted on such date will vest immediately in recognition of service during the prior Board year. The number of shares to be granted as equity compensation will be determined by
dividing the dollar amount of the applicable annual award by the fair market value per share of the Company’s common stock on the grant date, with any partial shares to be paid in cash.Supplemental Indenture

 Exhibit 4.1 
  

NDCHEALTH CORPORATION 
  
 Company 
  
 PHYSERV SOLUTIONS, INC. 
 NDC HEALTH PHARMACY SYSTEMS AND SERVICES, INC. 
 NDC OF CANADA, INC. 
  
 Subsidiary Guarantors 
  
 and 
  
 REGIONS BANK 
  
 Trustee 
  
 Supplemental Indenture 
  
 Dated as of December 21, 2005 
  
 to 
  
 Indenture 
  
 Dated as of November 26, 2002 
  
 10 1/2% Senior Subordinated Notes due 2012 

 SUPPLEMENTAL INDENTURE, (the “Supplemental Indenture”), dated as of December 21, 2005, among NDCHEALTH
CORPORATION, a corporation duly organized and existing under the laws of the State of Delaware (the “Company”), having its principal office at NDC Plaza, Atlanta, Georgia 30329-2010, PHYSERV SOLUTIONS, INC., a Delaware corporation, NDC
HEALTH PHARMACY SYSTEMS AND SERVICES, INC., a Delaware corporation, and NDC OF CANADA, INC., a Delaware corporation, and REGIONS BANK, an Alabama state banking corporation, as trustee (the “Trustee”), under an Indenture dated as of
November 26, 2002 (the “Indenture”). 
  
 RECITALS OF
THE COMPANY 
  
 WHEREAS, Section 902 of the Indenture
provides, among other things, that, with the consent of the Holders of at least a majority in principal amount of the Notes then outstanding, the Company, the Subsidiary Guarantors and the Trustee may amend or supplement the Indenture; and

  
 WHEREAS, all things necessary to make this Supplemental
Indenture a valid supplement to the Indenture in accordance with its terms have been done; 
  
 NOW, THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH: 
  
 The parties hereto hereby agree as follows: 
  
 Section 1. Effectiveness of Supplemental Indenture. 
  
 This Supplemental Indenture shall become effective as of the date hereof provided that the amendments to the Indenture set forth in Section 2 shall
not be operative until the date that (1) the Notes are accepted for purchase by the Company pursuant to the Offer to Purchase and Consent Solicitation Statement dated December 9, 2005 and (2) all outstanding indebtedness under the
Senior Credit Agreement has been paid in full and the commitments to lend thereunder have been terminated (the “Amendment Effective Date”). 
  
 Section 2. Amendments to Indenture. 
  
 (1) The following definitions are hereby added to Section 101 of the Indenture: 
  
 “Amendment Effective Date” shall mean the “Amendment Effective Date” as defined in the
Supplemental Indenture. 
  
 “Supplemental
Indenture” shall mean that certain Supplemental Indenture, dated as of December 21, 2005, between the Company, certain of its subsidiaries and the Trustee. 
  
 (2) The following definitions are hereby deleted from Section 101 of the Indenture: “Acquired Indebtedness,”
“Asset Sale,” “Attributable Debt,” “Average Life,” “Consolidated Adjusted Net Income,” “Consolidated Fixed Charge 

 Coverage Ratio,” “Consolidated Income Tax Expense,” “Consolidated Interest
Expense,” “Consolidated Non-Cash Charges,” “Current Assets,” “Current Liabilities,” “Excess Cash Flow,” “Excess Proceeds Offer,” “incur,” “Independent Financial Advisor,”
“Investment,” “Net Cash Proceeds,” “Permitted Indebtedness,” “Permitted Investments,” “Permitted Liens,” “Purchase Money Obligations,” “Replacement Assets,” “Restricted
Payments,” and “Sale and Leaseback Transaction.” 
  
 (3) Section 501 of the Indenture will be deleted in its entirety and replaced by the following: 
  
 Section 501. Events of Default. 
  

“Event of Default”, wherever used herein, means any one of the following events (whatever the reason for such Event of
Default and whether it shall be occasioned by the provisions of Article Twelve or be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any
administrative or governmental body): 
  
 (1) default in the payment of any interest on any Note when it becomes due and payable and continuance of such default for a period of 30 days (whether or not such payment shall be prohibited by Article Twelve); 
  
 (2) default in the payment of the principal of, or
premium, if any, on any Note at its Maturity (upon acceleration, optional redemption, required purchase or otherwise) (whether or not such payment shall be prohibited by Article Twelve); 
  
 (3) default in the performance, or breach, of the provisions of Article Eight, the failure to make or
consummate a Change in Control Offer in accordance with Section 1013; 
  
 (4) [Intentionally Omitted]; 
  
 (5) [Intentionally Omitted]; 
  
 (6) [Intentionally Omitted]; 
  
 (7) any Note Guarantee of a Material Subsidiary, or group of Restricted Subsidiaries that, taken together, would constitute a Material Subsidiary, ceases to be in full force and effect or is declared null and
void or any Subsidiary Guarantor which is a Material Subsidiary denies that it has any further liability under any Note Guarantee, or gives notice to such effect (in each case, other than by reason of the termination of this Indenture or the release
of any such Note Guarantee in accordance with this Indenture); 

 (8) the Company or any of its Material Subsidiaries pursuant to or within the
meaning of Bankruptcy Law: (A) commences a voluntary case; (B) consents to the entry of an order for relief against it in an involuntary case; (C) consents to the appointment of a Custodian of it or for all or substantially all of its
property; (D) makes a general assignment for the benefit of its creditors, or (E) admits in writing that it is generally not paying its debts (other than debts which are the subject of a bona fide dispute) as they become due; or

  
 (9) a court of competent jurisdiction
enters an order or decree under any Bankruptcy Law that remains unstayed and in effect for 60 days and: (A) is for relief against the Company or any of its Material Subsidiaries in an involuntary case; (B) appoints a Custodian of the
Company or any of its Material Subsidiaries or for all or substantially all of the property of the Company or any of its Material Subsidiaries; or (C) orders the liquidation of the Company or any of its Material Subsidiaries; provided that
clauses (A), (B) and (C) shall not apply to an Unrestricted Subsidiary, unless such action or proceeding has a material adverse effect on the interests of the Company or any Restricted Subsidiary. 
  
 (4) Section 801 of the Indenture will be deleted in its entirety and
replaced by the following: 
  
 Section 801. Company May Consolidate, Etc., Only on Certain Terms. 
  
 The Company shall not, in a single transaction or through a series of transactions, consolidate with or merge with or into any other
Person or sell, assign, convey, transfer, lease or otherwise dispose of all or substantially all of its properties and assets to any other Person or Persons or permit any of its Restricted Subsidiaries to enter into any such transaction or series of
transactions if such transaction or series of transactions, in the aggregate, would result in a sale, assignment, conveyance, transfer, lease or other disposition of all or substantially all of the properties and assets of the Company and its
Restricted Subsidiaries on a consolidated basis to any other Person or Persons, unless at the time and immediately after giving effect thereto: 
  
 (a) either (1) the Company shall be the continuing corporation or (2) the Person (if other than the Company) formed by such
consolidation or into which the Company or such Restricted Subsidiary is merged or the Person that acquires by sale, assignment, conveyance, transfer, lease or disposition all or substantially all of the properties and assets of the Company and its
Restricted Subsidiaries on a consolidated basis (the “Surviving Entity”) (i) shall be a corporation duly organized and validly existing under the laws of the United States of America, any state thereof or the District of Columbia and
(ii) shall expressly assume, by an indenture supplemental hereto, 

 executed and delivered to the Trustee, in form reasonably satisfactory to the Trustee, the Company’s
obligation for the due and punctual payment of the principal of (and premium, if any) and interest on all the Notes and the performance and observance of every covenant of this Indenture and the Registration Rights Agreement on the part of the
Company to be performed or observed; 
  
 (b)
[Intentionally Omitted]; 
  
 (c) [Intentionally
Omitted]; 
  
 (d) each Subsidiary Guarantor, if
any, unless it is the other party to the transactions described above, shall have by supplemental indenture confirmed that its Note Guarantee will apply to such Person’s obligations under this Indenture and the Notes; and 
  
 (e) the Company or the Surviving Entity shall have delivered
to the Trustee, in form and substance reasonably satisfactory to the Trustee, an Officers’ Certificate and an Opinion of Counsel, each stating that such consolidation, merger, sale, assignment, conveyance, transfer, lease or other disposition,
and if a supplemental indenture is required in connection with such transaction, such supplemental indenture, comply with this Section 801 and that all conditions precedent herein provided for relating to such transaction have been satisfied.

  
 (5) Section 802 of the Indenture will be deleted in its
entirety and replaced by the following: 
  
 Section 802. Subsidiary Guarantors May Consolidate, Etc., Only on Certain Terms. 
  
 Each Subsidiary Guarantor, if any (other than any Subsidiary whose Note Guarantee is being released pursuant to the provisions of
Section 1309 as a result of such transaction), shall not, and the Company shall not permit a Subsidiary Guarantor to, in a single transaction or through a series of related transactions, merge or consolidate with or into any other corporation
or other entity (other than the Company or any Subsidiary Guarantor), or sell, assign, convey, transfer, lease or otherwise dispose of all or substantially all of its properties and assets to any entity (other than the Company or any Subsidiary
Guarantor) unless at the time and after giving effect thereto: 
  
 (a) either (1) such Subsidiary Guarantor shall be the continuing corporation or partnership or (2) the Person (if other than such Subsidiary Guarantor) formed by such consolidation or into which such
Subsidiary Guarantor is merged or the entity which acquires by sale, assignment, conveyance, transfer, lease or other disposition of all or substantially all of the properties and assets of such Subsidiary 

 Guarantor, as the case may be, shall be a corporation organized and validly existing under the laws of
the United States, any state thereof or the District of Columbia, and shall expressly assume by an indenture supplemental hereto, executed and delivered to the Trustee, in form satisfactory to the Trustee, all obligations of such Subsidiary
Guarantor under its Note Guarantee and this Indenture; 
  
 (b) [Intentionally Omitted]; and 
  
 (c)
such Subsidiary Guarantor or such Person shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each stating that such consolidation, merger, sale, assignment, conveyance, transfer, lease or disposition and, if
a supplemental indenture is required in connection with such transaction, such supplemental indenture comply with this Section 802 and that all conditions precedent herein provided for relating to such transaction have been satisfied.

  
 (6) Section 1005 of the Indenture will be deleted in its
entirety and replaced by the following: 
  
 Section 1005. Payment of Taxes and Other Claims. 
  
 [Intentionally Omitted]. 
  
 (7)
Section 1006 of the Indenture will be deleted in its entirety and replaced by the following: 
  
 Section 1006. Maintenance of Properties. 
  
 [Intentionally Omitted]. 
  
 (8) Section 1007 of the Indenture will be deleted in its entirety and replaced by the following: 
  
 Section 1007. Statement by Officers as to
Default. 
  
 [Intentionally Omitted].

  
 (9) Section 1008 of the Indenture will be deleted in its
entirety and replaced by the following: 
  
 Section 1008. Limitation on Indebtedness. 
  
 [Intentionally Omitted]. 
  
 (10)
Section 1009 of the Indenture will be deleted in its entirety and replaced by the following: 
  
 Section 1009. Limitation on Restricted Payments. 
  
 [Intentionally Omitted]. 

 (11) Section 1010 of the Indenture will be deleted in its entirety and replaced by the following:

  
 Section 1010. Limitation on
Issuances and Sales of Equity Interests by Restricted Subsidiaries. 
  
 [Intentionally Omitted]. 
  
 (12)
Section 1011 of the Indenture will be deleted in its entirety and replaced by the following: 
  
 Section 1011. Limitation on Transactions with Affiliates. 
  
 [Intentionally Omitted]. 
  
 (13) Section 1012 of the Indenture will be deleted in its entirety and replaced by the following: 
  
 Section 1012. Limitation on Liens.

  
 [Intentionally Omitted]. 
  
 (14) Section 1014 of the Indenture will be deleted in its entirety and
replaced by the following: 
  
 Section 1014. Limitation on Sale of Assets. 
  
 [Intentionally Omitted]. 
  
 (15)
Section 1015 of the Indenture will be deleted in its entirety and replaced by the following: 
  
 Section 1015. Limitations on Guarantees of Indebtedness by Restricted Subsidiaries. 
  
 [Intentionally Omitted]. 
  
 (16) Section 1016 of the Indenture will be deleted in its entirety and
replaced by the following: 
  
 Section 1016. Limitation on Dividends and Other Payment Restrictions Affecting Restricted Subsidiaries. 
  
 [Intentionally Omitted]. 

 (17) Section 1018 of the Indenture will be deleted in its entirety and replaced by the following:

  
 Section 1018. Limitation on
Unrestricted Subsidiaries. 
  
 [Intentionally
Omitted]. 
  
 (18) Section 1019 of the Indenture will be
deleted in its entirety and replaced by the following: 
  
 Section 1019. Reports. 
  
 [Intentionally Omitted]. 
  
 (19) Section 1105 of
the Indenture will be deleted in its entirety and replaced by the following: 
  
 Section 1105. Notice of Redemption. 
  
 Notice of redemption shall be given in the manner provided for in Section 106 not less than three nor more than 60 days prior to the
Redemption Date, to each Holder of Notes to be redeemed. The Trustee shall give notice of redemption in the Company’s name and at the Company’s expense. 
  
 All notices of redemption shall state: 
  
 (1) the Redemption Date, 
  
 (2) the Redemption Price and the amount of accrued interest, if any, to the Redemption Date payable as
provided in Section 1107, 
  
 (3) if less
than all Outstanding Notes are to be redeemed, the identification of the particular Notes to be redeemed, as well as the aggregate principal amount of Notes to be redeemed and the aggregate principal amount of Notes to be outstanding after such
partial redemption, 
  
 (4) in case any Note is
to be redeemed in part only, the notice which relates to such Note shall state that on and after the Redemption Date, upon surrender of such Note, the Holder will receive, without charge, a new Note or Notes of authorized denominations for the
principal amount thereof remaining unredeemed, 
  
 (5) that on the Redemption Date the Redemption Price (and accrued interest, if any, to the Redemption Date payable as provided in Section 1107) shall become due and payable upon each such Note, or the portion thereof, to be redeemed,
and, unless the Company defaults in making the redemption payment, that interest on Notes called for redemption (or the portion thereof) will cease to accrue on and after said date, 

 (6) the place or places where such Notes are to be surrendered for payment of the
Redemption Price and accrued interest, if any, 
  
 (7) the name and address of the Paying Agent, 
  
 (8) that Notes called for redemption must be surrendered to the Paying Agent to collect the Redemption Price, 
  
 (9) the CUSIP number, and that no representation is made as to the accuracy or correctness of the CUSIP number, if any, listed in
such notice or printed on the Notes, and 
  
 (10) the paragraph of the Notes pursuant to which the Notes are to be redeemed. 
  
 (20) References to any of the defined terms and Sections eliminated above are eliminated in their entirety. 
  
 Section 3. Waiver. 
  
 Subject to the last sentence of Section 902(a) of the Indenture (to the extent it may be applicable), all Defaults and
Events of Default that may exist under the Indenture at the Amendment Effective Date are hereby waived. 
  
 Section 4. Governing Law. 
  
 This Supplemental Indenture and the Indenture, as amended hereby, shall be governed by and construed in accordance with the law of the State of New York. 
  
 Section 5. Counterparts. 
  
 This Supplemental Indenture may be executed in any number of counterparts, each of which shall be original; but such counterparts shall together
constitute but one and the same instrument. 
  
 Section 6. Separability
Clause. 
  
 In case any provision in this Supplemental
Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
  
 Section 7. Ratification. 
  
 Except as expressly amended by this Supplemental Indenture, each provision of the Indenture shall remain in full force and effect, and, as amended hereby,
the Indenture is in all respects agreed to, ratified and confirmed by each of the Company, the Subsidiary Guarantors and the Trustee. 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed as of
the day and year first above written. 
  

			
	 NDCHEALTH CORPORATION

		
	 By:
	 	 /s/ Randolph L.M. Hutto

	 Name:
	 	 Randolph L.M. Hutto

	 Title:
	 	 Executive Vice President

	
	 PHYSERV SOLUTIONS, INC.

		
	 By:
	 	 /s/ Randolph L.M. Hutto

	 Name:
	 	 Randolph L.M. Hutto

	 Title:
	 	 Executive Vice President

	
	 NDC HEALTH PHARMACY
 SYSTEMS AND SERVICES, INC.

		
	 By:
	 	 /s/ Randolph L.M. Hutto

	 Name:
	 	 Randolph L.M. Hutto

	 Title:
	 	 Executive Vice President

	
	 NDC OF CANADA, INC.

		
	 By:
	 	 /s/ Randolph L.M. Hutto

	 Name:
	 	 Randolph L.M. Hutto

	 Title:
	 	 Executive Vice President

	
	 REGIONS BANK,
 as Trustee

		
	 By:
	 	 /s/ Eric J. Knoll

	 Name:
	 	 Eric J. Knoll

	 Title:
	 	 Vice President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00095-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00095-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00095-of-00352.parquet"}]]